The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Belantamab treatment of multiple myeloma: Results from part 1 of the first-in-human phase 1/2 DREAMM-20 trial.
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Bradley Augustson
Consulting or Advisory Role - Johnson & Johnson
 
Linda Barton
No Relationships to Disclose
 
Edvan Crusoe
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Takeda
Other Relationship - Janssen
 
Jeffrey Huang
No Relationships to Disclose
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Marek Hus
No Relationships to Disclose
 
Karthik Ramasamy
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini Group; Oncopeptides; Pfizer; Sanofi; Takeda Recordati pharma
Speakers' Bureau - AbbVie; Adaptive Biotechnologies; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Menarini Group; Oncopeptides; Pfizer; Recordati pharma; Sanofi; Takeda
Research Funding - Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Takeda
Other Relationship - GlaxoSmithKline; Pfizer
 
Teruhito Takakuwa
Honoraria - Janssen; Sanofi
Speakers' Bureau - Janssen; Sanofi
Other Relationship - Bristol-Myers Squibb; GSK KK; Incyte Biosciences Japan GK; Pfizer
 
Dok Hyun Yoon
Honoraria - Celgene; Janssen; Kirin Pharmaceuticals; Roche; Takeda
Consulting or Advisory Role - ABclonal; Amgen; Celgene; GI cell; Janssen; Novartis; Pharos iBio; Roche
Research Funding - Boryung; Celltrion (Inst); Janssen Oncology; Roche/Genentech; Samyang
 
Rupam Pal
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Shreyan Banerjee
Employment - GlaxoSmithKline
 
Hari Narayan
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Wei Sun
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Malika Ahras
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Seema Shafi-Harji
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sarantos Kaptanis
Employment - GlaxoSmithKline
 
Giulia Fulci
Employment - GlaxoSmithKline
 
Brandon Kremer
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Chang-Ki Min
No Relationships to Disclose